PharmD_Rodriguez said:Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.
Second this. I had assumed I was the exception until I read this.
PharmD_Rodriguez said:Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.
Second this. I had assumed I was the exception until I read this.
The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.
One thing that is still open after HPLC_Greg’s answer:
What would you measure differently if you were starting again?
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.GutHealth said:For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.
Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.